Nebulised magnesium sulfate + standard care vs placebo + standard care
Incidence of admissions to the ICU · acute exacerbations of chronic obstructive pulmonary disease
It is very uncertain whether nebulised magnesium sulfate + standard care changes proportion of people requiring ICU admission compared with placebo + standard care (very low certainty).
1 finding from 1 review
- Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease 2022 · Cochrane Headline outcomes onlyOR 0.39 [0.15, 1]2 studies · 281 participantsVery low